CD44, a non-kinase transmembrane glycoprotein, is regard as a marker of cancer stem cell (CSC) and can regulate the properties of CSCs, including cellular plasticity, self-renewal, invasiveness and treatment resistance [55]. Here, CD44 is linked to cancer.